Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 17/20 | 0.64 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.64 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.64 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.64 |
| ▸ | FPR1 | P21462 | 1/20 | 0.64 |
| ▸ | FPR3 | P25089 | 1/20 | 0.64 |
| ▸ | GPR183 | P32249 | 1/20 | 0.64 |
| ▸ | APLNR | P35414 | 1/20 | 0.64 |
| ▸ | GPR65 | Q8IYL9 | 1/20 | 0.64 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.51 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.47 |
| ▸ | CYP4F11 | Q9HBI6 | 1/20 | 0.47 |
| ▸ | CYP4F12 | Q9HCS2 | 1/20 | 0.47 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.46 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19821417 | 0.84 | FFAR1 (0.84) | FFAR1FFAR4CHRM2S1PR1FPR1 | |
| SCHEMBL1551052 | 0.81 | FFAR1 (0.73) | FFAR1FFAR4CHRM2S1PR1FPR1 | |
| SCHEMBL1550693 | 0.80 | FFAR1 (0.68) | FFAR1FFAR4CHRM2S1PR1FPR1 | |
| SCHEMBL1551361 | 0.79 | FFAR1 (0.73) | FFAR1FFAR4CHRM2S1PR1FPR1 | |
| SCHEMBL1550423 | 0.79 | FFAR1 (0.69) | FFAR1FFAR4CHRM2S1PR1FPR1 | |
| SCHEMBL14924233 | 0.79 | FFAR1 (0.79) | FFAR1FFAR4CHRM2S1PR1FPR1 | |
| SCHEMBL29358680 | 0.79 | FFAR1 (1.00) | FFAR1FFAR4CHRM2S1PR1FPR1 | |
| SCHEMBL1551461 | 0.79 | FFAR1 (1.00) | FFAR1FFAR4CHRM2S1PR1FPR1 | |
| SCHEMBL1550405 | 0.78 | FFAR1 (0.73) | FFAR1FFAR4CHRM2S1PR1FPR1 | |
| SCHEMBL12064833 | 0.78 | ALOX5 (0.72) | ALOX5CYP4Z1CYP4F11CYP4F12CYP4F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11773077-B2 | Compounds containing carbon-carbon linker as GPR120 agonists | Piramal Enterprises Limited (IN) | 2023-10-03 | — | — | US | disclosed |
| US-20180030031-A1 | COMPOUNDS CONTAINING CARBON-CARBON LINKER AS GPR120 AGONISTS | Piramal Enterprises Limited (IN) | 2018-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11773077-B2 | Compounds containing carbon-carbon linker as GPR120 agonists | GPR180, GPR68, GPR88 | FFAR1 20/4885FFAR4 42/4885CHRM2 150/4885 |
| US-20180030031-A1 | COMPOUNDS CONTAINING CARBON-CARBON LINKER AS GPR120 AGONISTS | GPR180, GPR68, GPR88 | FFAR1 20/4885FFAR4 42/4885CHRM2 150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.